ProCE Banner Activity

CE

Digital Technologies in Diabetes Management: Considerations for Delivering State-of-the-Art Care

Multimedia
Interactive on demand webinar providing expert insights on strategies for successful implementation of digital technologies to improve outcomes in persons with diabetes.

Pharmacists : 1.50 contact {hours} ({0.15} CEUs)

Released: April 18, 2022

Expiration: April 17, 2023

No longer available for credit.

Share

Faculty

Diana Isaacs

Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP

Endocrine Clinical Pharmacy Specialist
CGM and Remote Monitoring Program Coordinator

Endocrinology and Metabolism Institute
Cleveland Clinic
Cleveland, Ohio

Provided by

Provided by ProCE, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Abbott Diabetes Care Inc.

Medtronic

Target Audience

The target audience for this activity is pharmacists, including community, ambulatory care, primary care, and clinical pharmacists, who care for patients with diabetes who would benefit from diabetes technology and pharmacy directors, chief pharmacy officers, and other stakeholders in pharmacy practice.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Evaluate new and emerging diabetes technologies, including their role in reducing A1C, hypoglycemia, and postprandial hyperglycemia and improving time in range
  • Identify methods to overcome potential barriers to incorporating CGM or insulin-delivery devices into the care of a patient with diabetes
  • Discuss the role of the pharmacist in utilization of diabetes technologies in practice, including patient engagement and education, shared decision-making, and counseling patients on how diabetes technology can improve adherence and glycemic outcomes

Faculty Disclosure

Primary Author

Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP

Endocrine Clinical Pharmacy Specialist
CGM and Remote Monitoring Program Coordinator

Endocrinology and Metabolism Institute
Cleveland Clinic
Cleveland, Ohio

Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP, has disclosed that she has received consultant/advisor/speaker fees from Abbott, Dexcom, Insulet, Klinio, Medtronic, and Novo Nordisk.

Instructions for Credit

ProCE, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-0000-22-094-H01-P has been assigned to this home study, application-based activity. This activity is approved for 1.5 contact hours (0.15 CEU) in states that recognize ACPE providers. The activity is provided at no cost to participants. Completion of an evaluation and post-test with a score of 70% or higher is required to receive CE credit. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.

Additional Information

Participation in this self-study activity should be completed in approximately 1.5 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from April 18, 2022, through April 17, 2023:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 70% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.


Goal


The goal of this activity is to improve the knowledge and competence of pharmacists about how current and emerging digital technology within diabetes care can improve glycemic control and how to best implement its use in clinical practice.